International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 5 , Pages 1369-1375 , 1 April 2009

Stereotactic Body Radiotherapy for Lesions of the Spine and Paraspinal Regions

  • John W. Nelson, M.D.

      Affiliations

    • Department of Radiation Oncology, Duke University Medical Center, Durham, NC
    • ,
  • David S. Yoo, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Duke University Medical Center, Durham, NC
    • ,
  • John H. Sampson, M.D., Ph.D.

      Affiliations

    • Department of Surgery, Duke University Medical Center, Durham, NC
    • ,
  • Robert E. Isaacs, M.D.

      Affiliations

    • Department of Surgery, Duke University Medical Center, Durham, NC
    • ,
  • Nicole A. Larrier, M.D.

      Affiliations

    • Department of Radiation Oncology, Duke University Medical Center, Durham, NC
    • ,
  • Lawrence B. Marks, M.D.

      Affiliations

    • Department of Radiation Oncology, Duke University Medical Center, Durham, NC
    • ,
  • Fang-Fang Yin, Ph.D.

      Affiliations

    • Department of Radiation Oncology, Duke University Medical Center, Durham, NC
    • ,
  • Q. Jackie Wu, Ph.D.

      Affiliations

    • Department of Radiation Oncology, Duke University Medical Center, Durham, NC
    • ,
  • Zhiheng Wang, Ph.D

      Affiliations

    • Department of Radiation Oncology, Duke University Medical Center, Durham, NC
    • ,
  • John P. Kirkpatrick, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Duke University Medical Center, Durham, NC
    • Corresponding Author InformationReprint requests to: John P. Kirkpatrick, M.D., Ph.D., Department of Radiation Oncology, Duke University Medical Center, Box 3085, Durham, NC 27710. Tel: (919) 668-5213; Fax: (919) 668-7345

Received 13 May 2008 ,Revised 13 June 2008 ,Accepted 20 June 2008.

References 

  1. Potters L, Steinberg M, Rose C, et al. American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2004;60:1026–1032
  2. Timmerman RD, Kavanagh BD, Cho LC, et al. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol. 2007;25:947–952
  3. Klimo P, Thompson CJ, Kestle JR, et al. A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease. Neuro-Oncology. 2005;7:64–76
  4. Gerszten PC, Burton SA, Quinn AE, et al. Radiosurgery for the treatment of spinal melanoma metastases. Stereotact Funct Neurosurg. 2005;83:213–221
  5. Chang EL, Shiu AS, Mendel E, et al. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine. 2007;7:151–160
  6. Gibbs IC, Kamnerdsupaphon P, Ryu MR, et al. Image-guided robotic radiosurgery for spinal metastases. Radiother Oncol. 2007;82:185–190
  7. Benzil DL, Saboori M, Mogilner AY, et al. Safety and efficacy of stereotactic radiosurgery for tumors of the spine. J Neurosurg. 2004;101(Suppl. 3):413–418
  8. Sahgal A, Choua D, Amesa C, et al. Proximity of spinous/paraspinous radiosurgery metastatic targets to the spinal cord versus risk of local failure. [Abstract] Int J Radiat Oncol Biol Phys. 2007;69:S243
  9. Ryu S, Jin JY, Jin R, et al. Partial volume tolerance of the spinal cord and complications of single-dose radiosurgery. Cancer. 2007;109:628–636
  10. Bentel GC, Marks LB. Patient positioning and immobilization in radiation oncology. New York: McGraw-Hill, Health Professions Division; 1999;
  11. Yoo S, Yin FF. Dosimetric feasibility of cone-beam CT-based treatment planning compared to CT-based treatment planning. Int J Radiat Oncol Biol Phys. 2006;66:1553–1561
  12. Yoo DS, Wang Z, Nelson J, et al. Improved target localization with 3D cone beam CT on-board imaging in stereotactic body radiation therapy. [Abstract] Int J Radiat Oncol Biol Phys. 2007;69:S36–S37
  13. Nieder C, Grosu AL, Andratschke NH, et al. Update of human spinal cord reirradiation tolerance based on additional data from 38 patients. Int J Radiat Oncol Biol Phys. 2006;66:1446–1449
  14. Schultheiss TE, Kun LE, Ang KK, et al. Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys. 1995;31:1093–1112
  15. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109–122
  16. Ang KK, Jiang GL, Feng Y, et al. Extent and kinetics of recovery of occult spinal cord injury. Int J Radiat Oncol Biol Phys. 2001;50:1013–1020
  17. Sminia P, Oldenburger F, Slotman BJ, et al. Re-irradiation of the human spinal cord. Strahlenther Onkol. 2002;178:453–456
  18. Nieder C, Grosu AL, Andratschke NH, et al. Proposal of human spinal cord reirradiation dose based on collection of data from 40 patients. Int J Radiat Oncol Biol Phys. 2005;61:851–855
  19. Godfrey DJ, Yin FF, Oldham M, et al. Digital tomosynthesis with an on-board kilovoltage imaging device. Int J Radiat Oncol Biol Phys. 2006;65:8–15
  20. Nielsen OS, Bentzen SM, Sandberg E, et al. Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases. Radiother Oncol. 1998;47:233–240
  21. Roos DE, Turner SL, O'Brien PC, et al. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol. 2005;75:54–63
  22. Hartsell WF, Scott CB, Bruner DW, et al. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst. 2005;97:798–804
  23. Withers HR, Taylor JM, Maciejewski B. Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys. 1988;14:751–759
  24. Knowles JF. The radiosensitivity of the guinea-pig spinal cord to X-rays: The effect of retreatment at one year and the effect of age at the time of irradiation. Int J Radiat Biol Relat Stud Phys Chem Med. 1983;44:433–442
  25. Ruifrok AC, Kleiboer BJ. van der Kogel AJ. Repair kinetics of radiation damage in the developing rat cervical spinal cord. Int J Radiat Biol. 1993;63:501–508
  26. Wong CS, Hao Y. Long-term recovery kinetics of radiation damage in rat spinal cord. Int J Radiat Oncol Biol Phys. 1997;37:171–179
  27. Ang KK, Price RE, Stephens LC, et al. The tolerance of primate spinal cord to re-irradiation. Int J Radiat Oncol Biol Phys. 1993;25:459–464
  28. Goetz C. Textbook of clinical neurology. 2nd ed.. Chicago, IL: Saunders; 2003;
  29. Philippens ME, Pop LA, Visser AG, et al. Dose-volume effects in rat thoracolumbar spinal cord: The effects of nonuniform dose distribution. Int J Radiat Oncol Biol Phys. 2007;69:204–213
  30. Coderre JA, Morris GM, Micca PL, et al. Late effects of radiation on the central nervous system: Role of vascular endothelial damage and glial stem cell survival. Radiat Res. 2006;166:495–503
  31. Bijl HP, van Luijk P, Coppes RP, et al. Dose-volume effects in the rat cervical spinal cord after proton irradiation. Int J Radiat Oncol Biol Phys. 2002;52:205–211
  32. Bijl HP, van Luijk P, Coppes RP, et al. Regional differences in radiosensitivity across the rat cervical spinal cord. Int J Radiat Oncol Biol Phys. 2005;61:543–551
  33. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66
  34. Motzer RJ, Bacik J, Murphy BA, et al. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Clin Oncol. 2002;20:289–296
  35. Svedman C, Sandstrom P, Pisa P, et al. A prospective phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma. Acta Oncol. 2006;45:870–875
  36. Lee J, Hodgson D, Chow E, et al. A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma. Cancer. 2005;104:1894–1900
  37. Wersall PJ, Blomgren H, Lax I, et al. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol. 2005;77:88–95
  38. Barendsen GW. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys. 1982;8:1981–1997
  39. Leith JT, Cook S, Chougule P, et al. Intrinsic and extrinsic characteristics of human tumors relevant to radiosurgery: Comparative cellular radiosensitivity and hypoxic percentages. Acta Neurochir Suppl. 1994;62:18–27
  40. Flickinger JC, Kondziolka D, Maitz AH, et al. An analysis of the dose-response for arteriovenous malformation radiosurgery and other factors affecting obliteration. Radiother Oncol. 2002;63:347–354
  41. Karlsson B, Lindqvist M, Blomgren H, et al. Long-term results after fractionated radiation therapy for large brain arteriovenous malformations. Neurosurgery. 2005;57:42–49discussion 42–49
  42. Ch'ang HJ, Maj JG, Paris F, et al. ATM regulates target switching to escalating doses of radiation in the intestines. Nat Med. 2005;11:484–490
  43. Park C, Papiez L, Zhang S, et al. Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70:847–852
  44. Kirkpatrick J, Meyer J, Marks L. The linear-quadratic model is inappropriate to model high-dose per fraction effects. Semin Radiat Oncol. 2008;18:240–243

 Presented in part at the 49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Los Angeles, CA, Oct 28–Nov 1, 2007.

 Conflict of interest: Drs. Yin, Wang, Marks, and Kirkpatrick have a research grant from Varian Medical Systems, Palo Alto, CA.

PII: S0360-3016(08)03102-7

doi: 10.1016/j.ijrobp.2008.06.1949

International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 5 , Pages 1369-1375 , 1 April 2009

Article Tools

* Image Usage & Resolution